Tag: Targeted drug delivery

The concept of targeted drug delivery traces back to Paul Ehrlich's 'magic bullet' idea, a century-old vision of selectively targeting a pathogen without harming the host. Today, the realization of this vision is manifested in two primary targeted drug delivery systems: passive and active targeting. These systems utilize nanoscale carriers to concentrate therapeutic agents at a specific site in the body, optimizing drug effectiveness while drastically reducing side effects on healthy tissue.

The global pharmaceutical drug delivery market was valued at approximately US$1.9 trillion in 2023 and is projected to grow, with oral delivery methods accounting for over 55% of the market share. Understanding **what are the different types of drug delivery** is crucial for appreciating advancements in modern medicine.

Globally, bacterial antimicrobial resistance was directly responsible for an estimated 1.27 million deaths in 2019, a figure projected to rise dramatically [1.9.1, 1.9.4]. This crisis fuels the need for novel therapeutic strategies, leading to the development of advanced systems that ask, **What is Trojan medication?** and how can it overcome these challenges.